Article
From Bench Top to Bedside
7 Nov 1997
Abstract excerpt
CANCER RESEARCHMore than 2 decades of research on oncogenes and tumor suppressors may finally pay off in a new generation of more specific, less toxic, cancer drugs. Some have already yielded promising results in cell culture studies and in animals, and are moving into tests in humans--and more are on the way. The targets of these drugs include cell surface receptors through which growth factors exert their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.